167 related articles for article (PubMed ID: 38311637)
41. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
42. Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer.
Zhou Z; Xie X; Wang X; Zhang X; Li W; Sun T; Cai Y; Wu J; Dang C; Zhang H
Front Genet; 2021; 12():623424. PubMed ID: 33664769
[TBL] [Abstract][Full Text] [Related]
43. Identification of TGF-β signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer.
Zeng C; He R; Dai Y; Lu X; Deng L; Zhu Q; Liu Y; Liu Q; Lu W; Wang Y; Jin J
Front Pharmacol; 2022; 13():1069204. PubMed ID: 36467074
[No Abstract] [Full Text] [Related]
44. A Prognostic Model for Colon Adenocarcinoma Patients Based on Ten Amino Acid Metabolism Related Genes.
Ren Y; He S; Feng S; Yang W
Front Public Health; 2022; 10():916364. PubMed ID: 35712285
[TBL] [Abstract][Full Text] [Related]
45. Construction and validation of a tumor mutational burden and immune-related prognostic model for predicting the prognosis of patients with lung squamous cell carcinoma.
Zhou Y; Xu M; Zhao K; Liu B
J Thorac Dis; 2023 Mar; 15(3):1319-1334. PubMed ID: 37065576
[TBL] [Abstract][Full Text] [Related]
46. Subtypes analysis and prognostic model construction based on lysosome-related genes in colon adenocarcinoma.
Chen Y; Lu Y; Huang C; Wu J; Shao Y; Wang Z; Zhang H; Fu Z
Front Genet; 2023; 14():1149995. PubMed ID: 37168510
[No Abstract] [Full Text] [Related]
47. Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.
Ma W; Li W; Xu L; Liu L; Xia Y; Yang L; Da M
Pathol Oncol Res; 2021; 27():1609852. PubMed ID: 34566519
[No Abstract] [Full Text] [Related]
48. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
49. Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma.
Gao B; Wang Y; Li C; Lu S
Front Immunol; 2023; 14():1114717. PubMed ID: 36814910
[TBL] [Abstract][Full Text] [Related]
50. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
51. Crosstalk of angiogenesis-related subtypes, establishment of a prognostic signature and immune infiltration characteristics in colorectal adenocarcinoma.
Cui G; Liu J; Wang M; Shon K; Wang C; Wei F; Sun Z
Front Immunol; 2022; 13():1049485. PubMed ID: 36505481
[TBL] [Abstract][Full Text] [Related]
52. Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer.
Wang Z; Zhang Q; Qi C; Bai Y; Zhao F; Chen H; Li Z; Wang X; Chen M; Gong J; Peng Z; Zhang X; Cai J; Chen S; Zhao X; Shen L; Li J
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35705314
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
54. Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.
Lin J; Lin Y; Huang Z; Li X
Comput Math Methods Med; 2020; 2020():8836493. PubMed ID: 33273963
[TBL] [Abstract][Full Text] [Related]
55. Establishment and Validation of a Genetic Label Associated With M2 Macrophage Infiltration to Predict Survival in Patients With Colon Cancer and to Assist in Immunotherapy.
Xu B; Peng Z; Yan G; Wang N; Chen M; Yao X; Sun M; An Y
Front Genet; 2021; 12():726387. PubMed ID: 34552622
[TBL] [Abstract][Full Text] [Related]
56. Construction and validation of immune-related LncRNAs classifier to predict prognosis and immunotherapy response in laryngeal squamous cell carcinoma.
Wang X; Pan Y; Ou Y; Duan T; Zou Y; Zhou X
World J Surg Oncol; 2022 May; 20(1):164. PubMed ID: 35606755
[TBL] [Abstract][Full Text] [Related]
57. Prognostic and immunotherapeutic significance of immunogenic cell death-related genes in colon adenocarcinoma patients.
Xu J; Yang J; Pan X; Wang J
Sci Rep; 2023 Nov; 13(1):19188. PubMed ID: 37932362
[TBL] [Abstract][Full Text] [Related]
58. Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy.
Xu M; Chang J; Wang W; Wang X; Wang X; Weng W; Tan C; Zhang M; Ni S; Wang L; Huang Z; Deng Z; Li W; Huang D; Sheng W
Front Immunol; 2022; 13():934083. PubMed ID: 35967414
[TBL] [Abstract][Full Text] [Related]
59. Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma.
Zhang L; Xu J; Chu X; Zhang H; Yao X; Zhang J; Guo Y
BMC Bioinformatics; 2022 Nov; 23(1):485. PubMed ID: 36384423
[TBL] [Abstract][Full Text] [Related]
60. Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma.
Ren Z; Wang Z; Gu D; Ma H; Zhu Y; Cai M; Zhang J
Front Cell Dev Biol; 2021; 9():740455. PubMed ID: 34746134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
